bromfenac
Selected indexed studies
- Bromfenac. (, 2006) [PMID:30000016]
- Topical bromfenac in VEGF-driven maculopathies: topical review and meta-analysis. (BMC Ophthalmol, 2024) [PMID:39180057]
- Topical bromfenac for prevention and treatment of cystoid macular edema following cataract surgery: a review. (Clin Ophthalmol, 2016) [PMID:27822006]
_Worker-drafted node — pending editorial review._
Connections
bromfenac is a side effect of
Sources
- Bromfenac. (2006) pubmed
- Topical bromfenac in VEGF-driven maculopathies: topical review and meta-analysis. (2024) pubmed
- Topical bromfenac for prevention and treatment of cystoid macular edema following cataract surgery: a review. (2016) pubmed
- Bromfenac Ophthalmic Solution 0.07%: A Review of Its Use After Cataract Surgery. (2015) pubmed
- Role of microsomal metabolism in bromfenac-induced cytotoxicity. (2024) pubmed
- Ophthalmic utility of topical bromfenac, a twice-daily nonsteroidal anti-inflammatory agent. (2009) pubmed
- Clinical pharmacokinetics and pharmacodynamics of bromfenac. (1999) pubmed
- Efficacy and safety of bromfenac 0.075% formulated in DuraSite for pain and inflammation in cataract surgery. (2019) pubmed
- A case of sodium bromfenac eye drop-induced toxic epidermal necrolysis and literature review. (2024) pubmed
- Bromfenac-induced neurotrophic keratitis in a corneal graft. (2022) pubmed